Glucocorticoids up-regulate leukotriene B4 receptor-1 expression during neutrophilic differentiation of HL-60 cells

Biochemical and Biophysical Research Communications

Volumn 309, Issue 1, 2003, Pages 114-119

  Obinata, Hideru ^a,b   Yokomizo, Takehiko ^b,c   Shimizu, Takao ^b,c   Izumi, Takashi ^a,b  

^a GUNMA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cellular differentiation; Host defense; Inflammation; Lipid mediators

Indexed keywords

COLECALCIFEROL; DEXAMETHASONE; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR 1; LEUKOTRIENE B4 RECEPTOR 2; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0042235195     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01554-7     Document Type: Article

References (23)

1. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1987;1171-1176.
2. Serhan C.N., Haeggstrom J.Z., Leslie C.C. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10:1996;1147-1158.
3. 4: metabolism and signal transduction. Arch. Biochem. Biophys. 385:2001;231-241.
4. Ford-Hutchinson A.W., Bray M.A., Doig M.V., Shipley M.E., Smith M.J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 286:1980;264-265.
5. Palmblad J., Gyllenhammar H., Lindgren J.A., Malmsten C.L. Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils. J. Immunol. 132:1984;3041-3045.
6. 4 that mediates chemotaxis. Nature. 387:1997;620-624.
7. 4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192:2000;421-432.
8. 4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J. Immunol. 168:2002;3570-3576.
9. 4 receptors in HL-60 cells. Blood. 81:1993;3395-3403.
10. Wallace A.D., Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoid. J. Biol. Chem. 276:2001;42714-42721.
11. Osburn D.L., Shao G., Seidel H.M., Schulman I.G. Ligand-dependent degradation of retinoid X receptor does not require transcriptional activity or coactivator interactions. Mol. Cell. Biol. 21:2001;4909-4918.
12. Zhu J., Gianni M., Kopf E., Honore N., Chelbi-Alix M., Koken M., Quignon F., Rochette-Egly C., The de H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. Proc. Natl. Acad. Sci. USA. 96:1999;14807-14812.
13. 4 receptor gene. J. Exp. Med. 192:2000;413-420.
14. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94:1998;557-572.
15. van der Velden V.H. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm. 7:1998;229-237.
16. Nakagawa M., Terashima T., D'Yachkova Y., Bondy G.P., Hogg J.C., van Eeden S.F. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation. 98:1998;2307-2313.
17. Bone R.C., Fisher C.J. Jr., Clemmer T.P., Slotman G.J., Metz C.A., Balk R.A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317:1987;653-658.
18. Gulsvik A., Kjelsberg F., Bergmann A., Froland S.S., Rootwelt K., Vale J.R. High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study. Respiration. 50:1986;252-257.
19. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154:1995;4719-4725.
20. Liles W.C., Dale D.C., Klebanoff S.J. Glucocorticoids inhibit apoptosis of human neutrophils. Blood. 86:1995;3181-3188.
21. 4 biosynthesis in neutrophils from patients with rheumatoid arthritis after a single glucocorticoid dose. Biochem. Pharmacol. 49:1995;243-248.
22. Goppelt-Struebe M., Schaefer D., Habenicht A.J. Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells. Br. J. Pharmacol. 122:1997;619-624.
23. Riddick C.A., Ring W.L., Baker J.R., Hodulik C.R., Bigby T.D. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur. J. Biochem. 246:1997;112-118.